Nature’s Sunshine Products (NASDAQ:NATR) Price Target Cut to $15.00

Nature’s Sunshine Products (NASDAQ:NATRGet Rating) had its target price lowered by research analysts at DA Davidson from $18.00 to $15.00 in a report released on Friday, The Fly reports. The firm currently has a “buy” rating on the stock. DA Davidson’s target price would suggest a potential upside of 68.16% from the company’s current price.

Separately, StockNews.com assumed coverage on Nature’s Sunshine Products in a research note on Wednesday, October 12th. They issued a “strong-buy” rating on the stock.

Nature’s Sunshine Products Trading Down 0.6 %

NASDAQ NATR opened at $8.92 on Friday. Nature’s Sunshine Products has a 12 month low of $7.95 and a 12 month high of $19.26. The stock has a market cap of $171.00 million, a P/E ratio of 16.22 and a beta of 0.83. The stock’s fifty day moving average price is $8.51 and its 200-day moving average price is $10.21.

Insider Transactions at Nature’s Sunshine Products

In other Nature’s Sunshine Products news, major shareholder Wynnefield Partners Small Cap purchased 9,622 shares of the stock in a transaction dated Thursday, August 25th. The shares were purchased at an average cost of $9.66 per share, with a total value of $92,948.52. Following the completion of the acquisition, the insider now directly owns 762,963 shares in the company, valued at approximately $7,370,222.58. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Over the last three months, insiders have purchased 15,105 shares of company stock valued at $144,882. Insiders own 5.41% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NATR. Lazard Asset Management LLC lifted its holdings in shares of Nature’s Sunshine Products by 50.8% during the second quarter. Lazard Asset Management LLC now owns 4,795 shares of the company’s stock valued at $51,000 after purchasing an additional 1,615 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Nature’s Sunshine Products by 1,065.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 7,074 shares of the company’s stock valued at $58,000 after acquiring an additional 6,467 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in Nature’s Sunshine Products by 18.7% in the second quarter. BNP Paribas Arbitrage SA now owns 6,606 shares of the company’s stock valued at $70,000 after acquiring an additional 1,039 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new position in Nature’s Sunshine Products in the third quarter valued at about $84,000. Finally, BNP Paribas Arbitrage SNC lifted its holdings in Nature’s Sunshine Products by 63.4% in the third quarter. BNP Paribas Arbitrage SNC now owns 10,791 shares of the company’s stock valued at $89,000 after acquiring an additional 4,185 shares during the period. 75.24% of the stock is owned by institutional investors.

Nature’s Sunshine Products Company Profile

(Get Rating)

Nature's Sunshine Products, Inc, a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

See Also

The Fly logo

Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.